Resources
- Cancer Center and Research Institute
- Contact Cancer Center and Research Institute
-
Cancer Research
- Cancer Research Home
-
Cancer Registries
- Cancer Registries Home
- UMMC Cancer Registry
- Mississippi Cancer Registry
- Clinical Trials
- For Students and Trainees
- Patient Support
- Give Now
- In the News
Newsletter December 2024
WORDS TO THE WISE
CODING DIAGNOSTIC CONFIRMATION FOR HEMATOPOIETIC AND LYMPHOID NEOPLASMS (SOURCE: NPCR DATA QUALITY CORNER)
Per STORE manual 2018 (page 143): o Assign code 3 when there is a histology positive for cancer AND positive immunophenotyping and/or positive genetic testing results.
Per Hematopoietic and Lymphoid Neoplasm Coding Manual (page 17–21):
Review the rules for coding histology when ambiguous terms are present prior to assign the diagnostic confirmation code.
Code 1 includes peripheral blood and bone marrow aspiration or biopsy.
Code 3 includes positive histology PLUS positive immunophenotyping or genetic testing.
Code 5 when the diagnosis of cancer is based on laboratory tests, tumor marker studies, genetics, or immunophenotyping that are diagnostic for that specific cancer. Laboratory tests are listed under Definitive Diagnostic Methods in the Hematopoietic Database. Do not assign code 5 when there is histologic confirmation.
Code 8 when the diagnosis is determined based on the physician’s clinical expertise, combined with the information from the biopsy, equivocal or negative tests, and the clinical symptoms. This is called a “diagnosis of exclusion” because the physician’s judgment and the work-up literally exclude all other possible diagnoses, leaving one diagnosis. Ambiguous terminology may precede the diagnosis.
flCCSC
FLccSC New for December
The FLccSC site is still down, but NAACCR has given us permission to share access to its webinars. If you are providing ODS services to a Mississippi facility, email me at lhamel@umc.edu and I can send you the links for recent webinars.
SUMMARY STAGE
SSDI - GRADE
SOLID TUMOR RULES
Hema-LYMPHOID NEOPLASM DATABASE
DRUG DATABASE
Mississippi Cancer Registry Home Page
Director UMMC & MCR: Deirdre Rogers, dbrogers@umc.edu
MCR Manager: Angel Davis, adavis6@umc.edu
Clinical Systems Analyst-Intermediate: Tresheena Boyd, tboyd@umc.edu
Data Quality Analyst–Trainer: Lisa Hamel, lhamel@umc.edu
Electronic Data Source Coordinator: Madeline Hall, mnhall@umc.edu
ODS-C Stacy Major, semajor@umc.edu
ODS-C Mallory R. Israel, misrael@umc.edu
ODS Laken A. Frederick, lfrederick@umc.edu
ODS Melody Brenemen, mbrenemen@umc.edu
Admin. Assistant Michelle Smith, mrsmith2@umc.edu
MISSISSIPPI CANCER REGISTRY WILL BE CLOSED THE FOLLOWING DAYS:
- DECEMBER 24, CHRISTMAS EVE
- DECEMBER 25, CHRISTMAS DAY
- JANUARY 1, NEW YEAR’S DAY